Animal health company Elanco (NYSE:ELAN) reported Q4 CY2024 results exceeding the market’s revenue expectations, but sales ...

Animal health company Elanco (NYSE:ELAN) will be announcing earnings results tomorrow before market open. Here’s what to look ...

Ladies and gentlemen, thank you for standing by. Welcome to Elanco Animal Health’s Fourth Quarter 2024 Earnings Conference ...

LEADING animal health company Elanco has announced that Zolvix Plus - a leading broad spectrum drench used in the sheep ...

Elanco has struck an agreement to distribute a vaccine that may protect cattle for up to 12 months against bird flu ...

Casey Locklear, DVM, US medical strategic lead for Elanco Animal Health and a practicing veterinarian in Texas, discussed Credelio Quattro chewable tablets in a dvm360 interview.

Stifel analyst Jonathan Block lowered the firm’s price target on Elanco (ELAN) to $15 from $16 and keeps a Buy rating on the shares. While the ...

The project is expected to encompass about 7.5 acres on the river’s western bank and will include new green spaces, an ...

Elanco Animal Health (NYSE:ELAN) stock falls as the company reports mixed Q4 2024 results, and sets 2025 outlook below consensus due to forex headwinds. Read more here.

Elanco Animal Health (NYSE:ELAN – Free Report) had its target price cut by UBS Group from $18.00 to $17.00 in a research note released on Wednesday morning,Benzinga reports. They currently have a buy ...

Barclays lowered the firm’s price target on Elanco (ELAN) to $19 from $20 and keeps an Overweight rating on the shares. The firm sees a “solid ...

Elanco Animal Health (NYSE:ELAN – Free Report) had its target price trimmed by Barclays from $20.00 to $19.00 in a research report released on Wednesday morning,Benzinga reports. The firm currently ...